Dr. Satish Wassori

Senior Consultant : Endocrinology and Metabolism

Fellow Of American College of Endocrinology (USA), MD Endocrinology, MD Medicine, MD Physician

Dr Satish Chander Wasoori is Senior Consultant Endocrinology and Metabolism with a professional experience of more than 20 years. He is Fellow of the American College of Endocrinology (FACE)– a prestigious award and recognition in the field of Endocrinology. He specializes in treating complex cases of Diabetes (T1DM, T2DM, MODY, Gestational). Thyroid Diseases, Metabolic Disorders (Obesity, LipidMetabolism, ,Hypertension),Growth Disorders,Cancers of Endocrine Glands, PCOS, Hirsutism, Osteoporosis, Diabetic Polyneuropathy.He is pioneer in introducing once weekly thyroxine for the treatment of hypothyroidism .

Call Now +91 9717189900


  • General Surgeon


  • Fellow Of American College of Endocrinology (USA) 2016
  • MD Endocrinology 2010
  • MD Medicine 1993
  • MD Physician 1990


  • Diabetes(T1DM, T2DM, MODY, Gestational)
  • Thyroid diseases
  • Metabolic Disorders (Obesity, Lipid Metabolism,Hypertension)
  • Growth Disorders
  • PCOS
  • Diabetic Polyneuropathy


  • American Association Of Clinical Endocrinologist (AACE)
  • American Diabetes Association (ADA)
  • European Society Of Endocrinology (ESE)
  • European Association for the Study of Diabetes (EASD)
  • American College of Physicians (ACP)
  • Research Society for the study of diabetes in India (RSSDI)
  • Indian Society of Critical Care Medicine(ISCCM)
  • Associations of Physicians of India (API) Haryana Chapter

Awards and Honors

  • Best paper award at AACE 2016, Orlando, USA. ‘’ once weekly Thyroxine for young and middle aged women for the treatment of hypothyroidism”


  • Weekly Dose of L-Thyroxine as a first line treatment for Hypothyroidism in young and middle aged working women.
  • Hypothyroidism- once a week treatment option in young and middle aged adults.
  • Management of Diabetic Peripheral Neuropathy (DPN) using low frequency Pulsed Electro Magnetic field.
  • The Joint Asia Diabetes Evaluation (JADE) program: a web based program to translate evidence to clinical practice in type 2 diabetes.
  • Hypoglycemic assessing tool (HAT STUDY)- self reported hypoglycemia: a global study of 24 countries with 27,585 insulin treated patients with diabetes